This commissioned review article was subject to full peer-review.
Review article: coeliac disease, new approaches to therapy
Version of Record online: 13 FEB 2012
© 2012 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 35, Issue 7, pages 768–781, April 2012
How to Cite
Rashtak, S. and Murray, J. A. (2012), Review article: coeliac disease, new approaches to therapy. Alimentary Pharmacology & Therapeutics, 35: 768–781. doi: 10.1111/j.1365-2036.2012.05013.x
- Issue online: 8 MAR 2012
- Version of Record online: 13 FEB 2012
- Manuscript Revised: 18 JAN 2012
- Manuscript Accepted: 18 JAN 2012
- Manuscript Revised: 3 APR 2011
- Manuscript Received: 10 MAR 2011
- National Institute of Health
Coeliac disease is managed by life-long gluten withdrawal from the diet. However, strict adherence to a gluten-free diet is difficult and is not always effective. Novel therapeutic approaches are needed to supplement or even replace the dietary treatment.
To review recent advances in new therapeutic options for coeliac disease.
A literature search was performed on MEDLINE, EMBASE, Web of Science, Scopus, DDW.org and ClinicalTrials.gov for English articles and abstracts. The search terms used included, but not limited to, ‘Celiac disease’, ‘new’, ‘novel’, ‘Advances’, ‘alternatives’ and ‘Drug therapy’. The cited articles were selected based on the relevancy to the review objective.
Several new therapeutic approaches for coeliac disease are currently under development by targeting its underlying pathogenesis. Alternative therapies range from reproduction of harmless wheat strains to immunomodulatory approaches. Some of these therapies such as enzymatic cleavage of gluten and permeability inhibitors have shown promise in clinical studies.
Gluten-free diet is still the only practical treatment for patients with coeliac disease. Novel strategies provide promise of alternative adjunctive approaches to diet restriction alone for patients with this disorder.